Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Giannantoni

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Current Drug Delivery|March 14, 2012
Botulinum toxin A in prostate disease: a venom from bench to bed-sideLuigi Mearini, Antonella Giannantoni
Expert Opinion on Pharmacotherapy|April 9, 2011
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladderJerilyn M Latini, Antonella Giannantoni
Toxins|September 5, 2019
Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-AnalysisAntonella Giannantoni, Marilena Gubbiotti, Vittorio Bini
Neurourology and Urodynamics|November 16, 2020
Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemicAntonella Giannantoni, Emanuele Rubilotta, Matteo Balzarro, et al.
Neurourology and Urodynamics|March 25, 2021
Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic painAntonella Giannantoni, Marilena Gubbiotti, Matteo Balzarro, et al.
Urologia|May 22, 2012
[Botulinum toxin type-A toxin activity on prostate cancer cell lines]Silvia Proietti, Vincenza Nardicchi, Massimo Porena, et al.
BJU International|July 13, 2006
The potential and promise of using botulinum toxin in the prostate glandYao-Chi Chuang, Antonella Giannantoni, Michael B Chancellor
Urologia|February 14, 2012
[Vesical urothelium and new concepts]Antonella Giannantoni, Silvia Proietti, Silvia Giovannozzi, et al.
European Urology|September 26, 2008
Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic resultsAntonella Giannantoni, Ettore Mearini, Michele Del Zingaro, et al.
Psychiatria Danubina|September 7, 2019
Urinary and bowel disfunction in autism spectrum disorder: a prospective, observational studyMarilena Gubbiotti, Sandro Elisei, Chiara Bedetti, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Current Drug Delivery|March 14, 2012
Botulinum toxin A in prostate disease: a venom from bench to bed-sideLuigi Mearini, Antonella Giannantoni
Expert Opinion on Pharmacotherapy|April 9, 2011
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladderJerilyn M Latini, Antonella Giannantoni
Toxins|September 5, 2019
Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-AnalysisAntonella Giannantoni, Marilena Gubbiotti, Vittorio Bini
Neurourology and Urodynamics|November 16, 2020
Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemicAntonella Giannantoni, Emanuele Rubilotta, Matteo Balzarro, et al.
Neurourology and Urodynamics|March 25, 2021
Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic painAntonella Giannantoni, Marilena Gubbiotti, Matteo Balzarro, et al.
Urologia|May 22, 2012
[Botulinum toxin type-A toxin activity on prostate cancer cell lines]Silvia Proietti, Vincenza Nardicchi, Massimo Porena, et al.
BJU International|July 13, 2006
The potential and promise of using botulinum toxin in the prostate glandYao-Chi Chuang, Antonella Giannantoni, Michael B Chancellor
Urologia|February 14, 2012
[Vesical urothelium and new concepts]Antonella Giannantoni, Silvia Proietti, Silvia Giovannozzi, et al.
European Urology|September 26, 2008
Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic resultsAntonella Giannantoni, Ettore Mearini, Michele Del Zingaro, et al.
Psychiatria Danubina|September 7, 2019
Urinary and bowel disfunction in autism spectrum disorder: a prospective, observational studyMarilena Gubbiotti, Sandro Elisei, Chiara Bedetti, et al.
Pageof 9